15d-PGJ2 exerts anti-angiogenic activity by inhibiting VEGF and angiopoietin-1 (Ang-1) in renal cancer (Yuan et al., 2005) and gastric cancer (Fu et al., 2006), respectively. Here, ANGPT1 is linked to renal carcinoma.